Japanese Prescription Drug Market Could Grow To ¥9 Trillion In 2016
This article was originally published in PharmAsia News
Executive Summary
Japanese marketing research company Tokyo-based Yano Research Institute estimates the therapeutic drug market in Japan will reach ¥9.16 trillion by 2016, a 23-percent increase compared to total sales in 2008. The reasons cited are a strong demand for drugs by an increasingly aging population coupled with healthcare reform centered on drug re-pricing policies that is estimated to slow down over the years. According to Yano Research, the single biggest factor impacting the market is the national price reduction policy conducted every two years. The company also estimated the market could shrink to ¥7.24 trillion if the re-pricing policy is to further accelerate. (Click here for more - Japanese language
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.